54gene, the health technology company centered on advancing the field of African genomics to unlock scientific discoveries as well as improve diagnostic and treatment outcomes within Africa and the global community, is creating a trust which it will use to invest up to 5% of future proceeds from the company’s commercial drug discovery program. The … Continue reading 54gene Launches Trust to Reinvest 5% of Proceeds from Commercial Drug Discovery Programs